WilmerHale‘s practice is valued by clients in pharmaceuticals and life sciences on regulatory questions relating to clinical trials, licensing and destruction agreements, with a particular strength in contentious cases. Hans-Georg Kamann is a highly experienced litigator with a growing regulatory practice, and Peter Gey has in-depth knowledge on the application of European and German competition law to matters pertaining to pharmaceutical advertising and distribution.
Legal 500 Editorial commentary
Key clients
- Becton Dickinson GmbH
- Bundesverband der Pharmazeutischen Industrie
- Deutsches Hörgeräte Institut GmbH
- Medtronic, Inc
- Institut Straumann AG
- ICHOM
- D.E. Shaw Research, LLC,
- Astria Therapeutics, Inc.
Work highlights
Defended a new Medtronic product in an IP dispute.
Advice and expert opinion on possible actions before the EU courts against the obligation imposed on pharmaceutical companies in the new Municipal Waste Water Directive to bear the costs of fourth stage of treatment of municipal waste water to remove micropollutants (total annual costs for the industry running into billions)
Successful defense in IP litigation concerning a new, highly innovative product from Medtronic, as well as IP litigation
Practice head
Hans-Georg Kamann
Other key lawyers
Peter Gey